About: Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.06 (-2.75%)
LSTA NASDAQ Lisata Therapeutics Inc.
Lisata Therapeutics Inc. share price
LSTA price activity
Last Price
$1.010
Change (24hr)
-0.05 USD (4.72%)
Volume
21.49K
Volume (4w avg)
-
Open
$1.06
Day Range
$1.01 - $1.07
Previous Close
$1.06
Last Trade
05 Nov, 3:54 pm GMT+0
Delayed
05 Nov, 3:54 pm GMT+0
LSTA price performance
Delayed
05 Nov, 3:54 pm GMT+0
LSTA details
LSTA Market Signals